IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.
Standard
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. / Belloni, Laura; Allweiss, Lena; Guerrieri, Francesca; Pediconi, Natalia; Volz, Tassilo; Pollicino, Teresa; Petersen, Joerg; Raimondo, Giovanni; Dandri-Petersen, Maura; Levrero, Massimo.
in: J CLIN INVEST, Jahrgang 122, Nr. 2, 2, 2012, S. 529-537.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.
AU - Belloni, Laura
AU - Allweiss, Lena
AU - Guerrieri, Francesca
AU - Pediconi, Natalia
AU - Volz, Tassilo
AU - Pollicino, Teresa
AU - Petersen, Joerg
AU - Raimondo, Giovanni
AU - Dandri-Petersen, Maura
AU - Levrero, Massimo
PY - 2012
Y1 - 2012
N2 - HBV infection remains a leading cause of death worldwide. IFN-? inhibits viral replication in vitro and in vivo, and pegylated IFN-? is a commonly administered treatment for individuals infected with HBV. The HBV genome contains a typical IFN-stimulated response element (ISRE), but the molecular mechanisms by which IFN-? suppresses HBV replication have not been established in relevant experimental systems. Here, we show that IFN-? inhibits HBV replication by decreasing the transcription of pregenomic RNA (pgRNA) and subgenomic RNA from the HBV covalently closed circular DNA (cccDNA) minichromosome, both in cultured cells in which HBV is replicating and in mice whose livers have been repopulated with human hepatocytes and infected with HBV. Administration of IFN-? resulted in cccDNA-bound histone hypoacetylation as well as active recruitment to the cccDNA of transcriptional corepressors. IFN-? treatment also reduced binding of the STAT1 and STAT2 transcription factors to active cccDNA. The inhibitory activity of IFN-? was linked to the IRSE, as IRSE-mutant HBV transcribed less pgRNA and could not be repressed by IFN-? treatment. Our results identify a molecular mechanism whereby IFN-? mediates epigenetic repression of HBV cccDNA transcriptional activity, which may assist in the development of novel effective therapeutics.
AB - HBV infection remains a leading cause of death worldwide. IFN-? inhibits viral replication in vitro and in vivo, and pegylated IFN-? is a commonly administered treatment for individuals infected with HBV. The HBV genome contains a typical IFN-stimulated response element (ISRE), but the molecular mechanisms by which IFN-? suppresses HBV replication have not been established in relevant experimental systems. Here, we show that IFN-? inhibits HBV replication by decreasing the transcription of pregenomic RNA (pgRNA) and subgenomic RNA from the HBV covalently closed circular DNA (cccDNA) minichromosome, both in cultured cells in which HBV is replicating and in mice whose livers have been repopulated with human hepatocytes and infected with HBV. Administration of IFN-? resulted in cccDNA-bound histone hypoacetylation as well as active recruitment to the cccDNA of transcriptional corepressors. IFN-? treatment also reduced binding of the STAT1 and STAT2 transcription factors to active cccDNA. The inhibitory activity of IFN-? was linked to the IRSE, as IRSE-mutant HBV transcribed less pgRNA and could not be repressed by IFN-? treatment. Our results identify a molecular mechanism whereby IFN-? mediates epigenetic repression of HBV cccDNA transcriptional activity, which may assist in the development of novel effective therapeutics.
KW - Animals
KW - Humans
KW - Mice
KW - Mice, Transgenic
KW - Cell Culture Techniques
KW - Mice, SCID
KW - Virus Replication
KW - Transcription, Genetic
KW - Chimerism
KW - DNA, Circular/genetics/metabolism
KW - Epigenesis, Genetic
KW - Hepatitis B virus/genetics/metabolism
KW - Interferon-alpha/metabolism
KW - Animals
KW - Humans
KW - Mice
KW - Mice, Transgenic
KW - Cell Culture Techniques
KW - Mice, SCID
KW - Virus Replication
KW - Transcription, Genetic
KW - Chimerism
KW - DNA, Circular/genetics/metabolism
KW - Epigenesis, Genetic
KW - Hepatitis B virus/genetics/metabolism
KW - Interferon-alpha/metabolism
M3 - SCORING: Journal article
VL - 122
SP - 529
EP - 537
JO - J CLIN INVEST
JF - J CLIN INVEST
SN - 0021-9738
IS - 2
M1 - 2
ER -